By Mike Barrett
It has been nearly 20 years since a new drug has been developed to combat Alzheimer’s disease. Thankfully, it won’t be another 20 years until such a feat is accomplished, as a new drug called Oligomannate has been approved for the treatment of “mild to moderate Alzheimer’s disease and improving cognitive function.” Only thing is – the approval takes place in China, and has yet to go through the proper channels to become approved by the Food and Drug Administration.
?Dementia, used to describe a decline in cognitive function and memory, is said to be one of the costliest conditions …read more
Source: naturalsociety.com
Thanks! Share it with your friends!
Tweet
Share
Pin It
LinkedIn
Google+
Reddit
Tumblr